ArticleJournal of clinical medicine2026
Management of Rituximab-Associated Hypersensitivity Reactions with Successfully Applied Desensitization Protocols: A Clinical Experience of 46 Infusions in 11 Patients.
Ömer Candar, Vildan Özkocaman, Raziye Tülümen Öztürk, Tuba Ersal, Esra Gülderen, Cumali Yalçın, Sinem Çubukçu, Tuba Güllü Koca, Fazıl Çağrı Hunutlu, Şeyma Yavuz and 2 more
Abstract read
In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Ömer CandarDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.
Vildan ÖzkocamanDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.
Raziye Tülümen ÖztürkDivision of Allergy and Immunology, Department of Chest Diseases, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.
Tuba ErsalDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.ORCID 0000-0001-5419-3221 Esra GülderenDepartment of Internal Medicine, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.ORCID 0009-0001-6744-9676 Cumali YalçınDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.ORCID 0000-0002-5129-2977 Sinem ÇubukçuDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.
Tuba Güllü KocaDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.
Fazıl Çağrı HunutluDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.ORCID 0000-0002-4991-9830 Şeyma YavuzDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.
Dane EdigerDivision of Allergy and Immunology, Department of Chest Diseases, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.ORCID 0000-0002-2954-4293 Fahir ÖzkalemkaşDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey.ORCID 0000-0001-9710-134X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
allergydesensitizationleukemialymphomarituximab
Identifiers
PMID42279029
PMCPMC13257869
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390